| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.503 | 98 | 0 | 0 | 0 | 2.800 | 14.465 | 6.926 | 0 | 0 |
| Total Income - EUR | 5.505 | 98 | 0 | 0 | 0 | 10.415 | 14.495 | 6.926 | 0 | 0 |
| Total Expenses - EUR | 11.086 | 888 | 0 | 0 | 0 | 5.644 | 15.113 | 2.814 | 56 | 0 |
| Gross Profit/Loss - EUR | -5.582 | -790 | 0 | 0 | 0 | 4.771 | -618 | 4.112 | -56 | 0 |
| Net Profit/Loss - EUR | -5.747 | -793 | 0 | 0 | 0 | 4.687 | -1.053 | 3.904 | -56 | 0 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biorevial Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 791 | 716 | 704 | 691 | 21 | 278 | 130 | 56 | 0 | 0 |
| Current Assets | 7.661 | 137 | 134 | 132 | 786 | 1.543 | 2.264 | 5.121 | 5.057 | 5.028 |
| Inventories | 6.574 | 120 | 118 | 116 | 114 | 84 | 680 | 1.056 | 1.053 | 1.059 |
| Receivables | 454 | 16 | 15 | 15 | 671 | 902 | 1.509 | 0 | 0 | 0 |
| Cash | 633 | 0 | 0 | 0 | 0 | 558 | 75 | 4.065 | 4.004 | 3.969 |
| Shareholders Funds | -22.841 | -23.401 | -23.005 | -22.582 | -22.145 | -17.034 | -17.709 | -13.859 | -13.873 | -13.796 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 45 | 44 | 45 | 44 | 44 |
| Debts | 31.293 | 24.253 | 23.843 | 23.405 | 22.952 | 18.924 | 20.104 | 19.037 | 18.930 | 18.824 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6220 - 6220" | |||||||||
| CAEN Financial Year |
9512
|
|||||||||
Comments - Biorevial Srl